NCT03517982View on ClinicalTrials.gov

Generic Mycophenolate Mofetil Safety Study for Prophylaxis in de Novo Renal Transplant Patients in Jordan

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Acute Transplant Rejection in Patients Receiving Allogeneic Renal Transplant
Interventions
DRUG

Mycophenolate Mofetil

Film Coated Tablet, each tablet contains 500mg Mycophenolate Mofetil

Trial Locations (1)

Unknown

Prince Hamza Hospital, Amman

Sponsors
All Listed Sponsors
lead

Hikma Pharmaceuticals LLC

INDUSTRY

NCT03517982 - Generic Mycophenolate Mofetil Safety Study for Prophylaxis in de Novo Renal Transplant Patients in Jordan | Biotech Hunter | Biotech Hunter